Projected Income Statement: 3M Company

Forecast Balance Sheet: 3M Company

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 12,799 12,046 10,049 5,316 6,669 8,826 8,988 7,409
Change - -5.88% -16.58% -47.1% 25.45% 32.34% 1.84% -17.57%
Announcement Date 1/25/22 1/24/23 1/23/24 1/21/25 1/20/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: 3M Company

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 1,603 1,749 1,615 1,181 910 1,092 1,117 1,160
Change - 9.11% -7.66% -26.87% -22.95% 20.03% 2.24% 3.87%
Free Cash Flow (FCF) 1 5,851 3,842 5,065 638 1,396 3,222 4,494 4,106
Change - -34.34% 31.83% -87.4% 118.81% 130.84% 39.44% -8.62%
Announcement Date 1/25/22 1/24/23 1/23/24 1/21/25 1/20/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: 3M Company

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 26.26% 26.14% 24.93% 26.1% 28.84% 29.11% 30.24% 30.49%
EBIT Margin (%) 20.84% 20.79% 19.55% 21.44% 23.45% 24.19% 25.38% 26.05%
EBT Margin (%) 20.38% 18.67% -29.64% 20.39% 17.35% 20.68% 23.29% 23.56%
Net margin (%) 16.75% 16.88% -21.4% 17.66% 13.39% 15.98% 18.49% 18.73%
FCF margin (%) 16.55% 11.22% 15.5% 2.7% 5.75% 12.67% 16.91% 14.9%
FCF / Net Income (%) 98.82% 66.51% -72.41% 15.29% 42.95% 79.29% 91.43% 79.57%

Profitability

        
ROA 12.54% 12.35% -14.42% 9.23% 8.38% 11.67% 13.58% 15.1%
ROE 42.22% 38.38% 52.16% 100.64% 75.22% 98.39% 86.78% 61.14%

Financial Health

        
Leverage (Debt/EBITDA) 1.38x 1.35x 1.23x 0.86x 0.95x 1.19x 1.12x 0.88x
Debt / Free cash flow 2.19x 3.14x 1.98x 8.33x 4.78x 2.74x 2x 1.8x

Capital Intensity

        
CAPEX / Current Assets (%) 4.53% 5.11% 4.94% 5% 3.75% 4.29% 4.2% 4.21%
CAPEX / EBITDA (%) 17.27% 19.55% 19.82% 19.15% 13% 14.75% 13.9% 13.81%
CAPEX / FCF (%) 27.4% 45.52% 31.89% 185.11% 65.19% 33.89% 24.85% 28.25%

Items per share

        
Cash flow per share 1 12.74 9.85 12.06 3.293 4.26 9.475 9.196 9.758
Change - -22.65% 22.43% -72.7% 29.37% 122.42% -2.95% 6.11%
Dividend per Share 1 5.92 5.96 6 3.61 2.92 3.12 3.387 3.616
Change - 0.68% 0.67% -39.83% -19.11% 6.85% 8.55% 6.78%
Book Value Per Share 1 26.44 26.02 8.789 7.218 8.952 7.609 11.52 16.64
Change - -1.56% -66.23% -17.87% 24.02% -15% 51.45% 44.44%
EPS 1 10.12 10.18 -12.63 7.55 6 7.489 9.354 9.765
Change - 0.59% -224.07% 159.78% -20.53% 24.81% 24.91% 4.4%
Nbr of stocks (in thousands) 576,253 576,253 552,317 544,559 531,225 515,722 515,722 515,722
Announcement Date 1/25/22 1/24/23 1/23/24 1/21/25 1/20/26 - - -
1USD
Estimates
2026 *2027 *
P/E 21.8x 17.4x
PBR 21.4x 14.1x
EV / Sales 3.65x 3.5x
Yield 1.91% 2.08%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
163.02USD
Average target price
186.98USD
Spread / Average Target
+14.70%

Quarterly revenue - Rate of surprise